Increased globulin and its association with hemorrhagic transformation in patients receiving intra-arterial thrombolysis therapy

Neuroscience Bulletin

Volumn 30, Issue 3, 2014, Pages 469-476

  Xing, Yingqi ^a   Guo, Zhen Ni ^a   Yan, Shuo ^a   Jin, Hang ^a   Wang, Shouchun ^a   Yang, Yi ^a  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

globulin; hemorrhagic transformation; intra arterial thrombolysis

Indexed keywords

ALTEPLASE; GLOBULIN; UROKINASE; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE DISEASE; ADULT; ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CONTROLLED STUDY; FEMALE; HEMORRHAGIC TRANSFORMATION; HUMAN; INTRA ARTERIAL THROMBOLYSIS THERAPY; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PROTHROMBIN TIME; RETROSPECTIVE STUDY; RISK FACTOR; AGED; CEREBRAL HEMORRHAGE; CHEMICALLY INDUCED; COMPUTED TOMOGRAPHY SCANNER; FIBRINOLYTIC THERAPY; METABOLISM; NONPARAMETRIC TEST; STATISTICAL MODEL;

AGED; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; FEMALE; GLOBULINS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; STATISTICS, NONPARAMETRIC; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TOMOGRAPHY SCANNERS, X-RAY COMPUTED;

EID: 84902312884     PISSN: 16737067     EISSN: 19958218     Source Type: Journal    
DOI: 10.1007/s12264-013-1440-x     Document Type: Article

References (29)

1. Jaillard A, Cornu C, Durieux A, Moulin T, Boutitie F, Lees KR, et al. Hemorrhagic transformation in acute ischemic stroke. The MAST-E study. MAST-E Group. Stroke 1999, 30: 1326-1332. (Pubitemid 29296057)
2. Bang OY, Saver JL, Kim SJ, Kim GM, Chung CS, Ovbiagele B, et al. Collateral flow averts hemorrhagic transformation after endovascular therapy for acute ischemic stroke. Stroke 2011, 42: 2235-2239.
3. Kidwell CS, Saver JL, Carneado J, Sayre J, Starkman S, Duckwiler G, et al. Predictors of hemorrhagic transformation in patients receiving intra-arterial thrombolysis. Stroke 2002, 33: 717-724. (Pubitemid 34203996)
4. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group. Stroke 1997, 28: 2109-2118.
5. Molina CA, Alvarez-Sabin J, Montaner J, Abilleira S, Arenillas JF, Coscojuela P, et al. Thrombolysis-related hemorrhagic infarction: a marker of early reperfusion, reduced infarct size, and improved outcome in patients with proximal middle cerebral artery occlusion. Stroke 2002, 33: 1551-1556. (Pubitemid 34619956)
6. Lansberg MG, Albers GW, Wijman CA. Symptomatic intracerebral hemorrhage following thrombolytic therapy for acute ischemic stroke: a review of the risk factors. Cerebrovasc Dis 2007, 24: 1-10.
7. D'Amelio M, Terruso V, Famoso G, Ragonese P, Aridon P, Savettieri G. Cholesterol levels and risk of hemorrhagic transformation after acute ischemic stroke. Cerebrovasc Dis 2011, 32: 234-238.
8. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995, 274: 1017-1025.
9. Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 1998, 352: 1245-1251.
10. Um J Y, Jeong HJ, Park RK, Hong SH, Kim HM. Aspects of gene polymorphisms in cerebral infarction: inflammatory cytokines. Cell Mol Life Sci 2005, 62: 824-833. (Pubitemid 40655632)
11. Ji J, Liu HL, Cheng JL. Effects of "three ways" method of acupuncture on serum levels of tumor necrosis factor-alpha and interleukin-1beta patients with acute ischemic cerebrovascular diseases. Zhongguo Zhong Xi Yi Jie He Za Zhi 2006, 26: 500-503.
12. Fassbender K, Rossol S, Kammer T, Daffertshofer M, Wirth S, Dollman M, et al. Proinflammatory cytokines in serum of patients with acute cerebral ischemia: kinetics of secretion and relation to the extent of brain damage and outcome of disease. J Neurol Sci 1994, 122: 135-139.
13. Jickling GC, Ander BP, Stamova B, Zhan X, Liu D, Bsc LR, et al. RNA in blood is altered prior to hemorrhagic transformation in ischemic stroke. Ann Neurol 2013. Doi: 10.1002/ana.23883.
14. Woods A, Brull DJ, Humphries SE, Montgomery HE. Genetics of inflammation and risk of coronary artery disease: the central role of interleukin-6. Eur Heart J 2000, 21: 1574-1583.
15. Beamer N, Coull BM, Sexton G, de Garmo P, Knox R, Seaman G. Fibrinogen and the albumin-globulin ratio in recurrent stroke. Stroke 1993, 24: 1133-1139. (Pubitemid 23237549)
16. Marinkovic S, Jahreis GP, Wong GG, Baumann H. IL-6 modulates the synthesis of a specific set of acute phase plasma proteins in vivo. J Immunol 1989, 142: 808-812.
17. Lyoumi S, Tamion F, Petit J, Dechelotte P, Dauguet C, Scotte M, et al. Induction and modulation of acute-phase response by protein malnutrition in rats: comparative effect of systemic and localized inflammation on interleukin-6 and acute-phase protein synthesis. J Nutr 1998, 128: 166-174. (Pubitemid 28124981)
18. Dayer JM, Choy E. Therapeutic targets in rheumatoid arthritis: the interleukin-6 receptor. Rheumatology 2010, 49: 15-24.
19. Huwiler A, A kool el S, Aschrafi A, Hamada FM, Pfeilschifter J, Eberhardt W. ATP potentiates interleukin-1 beta-induced MMP-9 expression in mesangial cells via recruitment of the ELAV protein HuR. J Biol Chem 2003, 278: 51758-51769. (Pubitemid 38020422)
20. Lee HS, Miau LH, Chen CH, Chiou LL, Huang GT, Yang PM, et al. Differential role of p38 in IL-1alpha induction of MMP-9 and MMP-13 in an established liver myofibroblast cell line. J Biomed Sci 2003, 10: 757-765. (Pubitemid 38032492)
21. Reihmane D, Jurka A, Tretjakovs P. The relationship between maximal exercise-induced increases in serum IL-6, MPO and MMP-9 concentrations. Scand J Immunol 2012, 76: 188-192.
22. Li X, Wang R, Wang X, Xue X, Ran D, Wang S. Relevance of IL-6 and MMP-9 to cerebral arteriovenous malformation and hemorrhage. Mol Med Rep 2013, 7: 1261-1266.
23. Castellanos M, Leira R, Serena J, Pumar JM, Lizasoain I, Castillo J, et al. Plasma metalloproteinase-9 concentration predicts hemorrhagic transformation in acute ischemic stroke. Stroke 2003, 34: 40-46.
24. Sumii T, Lo EH. I nvolvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats. Stroke 2002, 33: 831-836. (Pubitemid 34204013)
25. Paciaroni M, Agnelli G, Caso V, Corea F, Ageno W, Alberti A, et al. Acute hyperglycemia and early hemorrhagic transformation in ischemic stroke. Cerebrovasc Dis 2009, 28: 119-123.
26. Kimura K, Iguchi Y, Shibazaki K, Aoki J, Terasawa Y. Hemorrhagic transformation of ischemic brain tissue after t-PA thrombolysis as detected by MRI may be asymptomatic, but impair neurological recovery. J Neurol Sci 2008, 272: 136-142.
27. Adams HP, Jr., Adams RJ, Brott T, del Zoppo GJ, Furlan A, Goldstein LB, et al. Guidelines for the early management of patients with ischemic stroke: A scientific statement from the Stroke Council of the American Stroke Association. Stroke 2003, 34: 1056-1083. (Pubitemid 36402991)
28. Adams HP, Jr., del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 2007, 38: 1655-1711.
29. Hallevi H, Barreto AD, Liebeskind DS, Morales MM, Martin-Schild SB, Abraham AT, et al. Identifying patients at high risk for poor outcome after intra-arterial therapy for acute ischemic stroke. Stroke 2009, 40: 1780-1785.